Proton pump inhibitor: The dual role in gastric cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Joo, Moon Kyung | - |
dc.contributor.author | Park, Jong-Jae | - |
dc.contributor.author | Chun, Hoon Jai | - |
dc.date.accessioned | 2021-09-01T15:05:52Z | - |
dc.date.available | 2021-09-01T15:05:52Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2019-05-07 | - |
dc.identifier.issn | 1007-9327 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/65442 | - |
dc.description.abstract | Proton pump inhibitors (PPIs) are one of the most frequently used medications for upper gastrointestinal diseases. However, a number of physicians have raised concern about the serious side effects of long-term use of PPIs, including the development of gastric cancer. Recent epidemiological studies have reported a significant association between long-term PPI intake and the risk of gastric cancer, even after successful Helicohacter pylori eradication. However, the effects of PPIs on the development of pre-malignant conditions such as atrophic gastritis or intestinal metaplasia are not fully known, suggesting the need for comprehensive and confirmative studies are needed in the future. Meanwhile, several experimental studies have demonstrated the effects of PPIs in reducing chemoresistance in gastric cancer cells by modulating the acidic microenvironment, cancer sternness and signal transducer and activator of transcription 3 (STAT3) signaling pathway. The inhibitory effects of PPIs on STAT3 activity may overcome drug resistance and enhance the efficacy of conventional or targeted chemotherapeutic agents. Taken together, PPIs may "play dual role" in gastric carcinogenesis and treatment of gastric cancer. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | BAISHIDENG PUBLISHING GROUP INC | - |
dc.subject | HELICOBACTER-PYLORI INFECTION | - |
dc.subject | ACID-SUPPRESSIVE DRUGS | - |
dc.subject | LYMPH-NODE METASTASIS | - |
dc.subject | HEPATOCELLULAR-CARCINOMA | - |
dc.subject | ANTITUMOR-ACTIVITY | - |
dc.subject | SERUM GASTRIN | - |
dc.subject | STEM-CELLS | - |
dc.subject | PHASE-I | - |
dc.subject | STAT3 | - |
dc.subject | RESISTANCE | - |
dc.title | Proton pump inhibitor: The dual role in gastric cancer | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Joo, Moon Kyung | - |
dc.contributor.affiliatedAuthor | Chun, Hoon Jai | - |
dc.identifier.doi | 10.3748/wjg.v25.i17.2058 | - |
dc.identifier.scopusid | 2-s2.0-85065887173 | - |
dc.identifier.wosid | 000466977300004 | - |
dc.identifier.bibliographicCitation | WORLD JOURNAL OF GASTROENTEROLOGY, v.25, no.17, pp.2058 - 2070 | - |
dc.relation.isPartOf | WORLD JOURNAL OF GASTROENTEROLOGY | - |
dc.citation.title | WORLD JOURNAL OF GASTROENTEROLOGY | - |
dc.citation.volume | 25 | - |
dc.citation.number | 17 | - |
dc.citation.startPage | 2058 | - |
dc.citation.endPage | 2070 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Gastroenterology & Hepatology | - |
dc.relation.journalWebOfScienceCategory | Gastroenterology & Hepatology | - |
dc.subject.keywordPlus | HELICOBACTER-PYLORI INFECTION | - |
dc.subject.keywordPlus | ACID-SUPPRESSIVE DRUGS | - |
dc.subject.keywordPlus | LYMPH-NODE METASTASIS | - |
dc.subject.keywordPlus | HEPATOCELLULAR-CARCINOMA | - |
dc.subject.keywordPlus | ANTITUMOR-ACTIVITY | - |
dc.subject.keywordPlus | SERUM GASTRIN | - |
dc.subject.keywordPlus | STEM-CELLS | - |
dc.subject.keywordPlus | PHASE-I | - |
dc.subject.keywordPlus | STAT3 | - |
dc.subject.keywordPlus | RESISTANCE | - |
dc.subject.keywordAuthor | Proton pump inhibitor | - |
dc.subject.keywordAuthor | Gastric cancer | - |
dc.subject.keywordAuthor | Drug resistance | - |
dc.subject.keywordAuthor | Signal transducer and activator of transcription 3 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.